Literature DB >> 9713620

Renal calculi following superior mesenteric artery occlusion.

L Ranganath1, S R Gould, P F Goddard.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9713620      PMCID: PMC2360910          DOI: 10.1136/pgmj.74.871.303

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid.

Authors:  M Lindsjö; B Fellström; S Ljunghall; B Wikström; B G Danielson
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

2.  Mechanism for hyperoxaluria in patients with ileal dysfunction.

Authors:  V S Chadwick; K Modha; R H Dowling
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

3.  Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome.

Authors:  L H Smith; H Fromm; A F Hofmann
Journal:  N Engl J Med       Date:  1972-06-29       Impact factor: 91.245

Review 4.  Hyperoxaluria and renal calculi.

Authors:  R G Woolfson; M A Mansell
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

5.  Calcium oxalate lithiasis produced by pyridoxine deficiency and inhibition with high magnesium diets.

Authors:  E S Lyon; T A Borden; J E Ellis; C W Vermeulen
Journal:  Invest Urol       Date:  1966-09

6.  Effect of bile salts and fatty acids on the colonic absorption of oxalate.

Authors:  J W Dobbins; H J Binder
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

7.  Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium.

Authors:  D E Barilla; C Notz; D Kennedy; C Y Pak
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

8.  Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity.

Authors:  E Hylander; S Jarnum; K Nielsen
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.